T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortinet
FTNT
|
+$2.03B |
| 2 |
Rockwell Automation
ROK
|
+$1.44B |
| 3 |
Autodesk
ADSK
|
+$1.15B |
| 4 |
Citigroup
C
|
+$975M |
| 5 |
ConocoPhillips
COP
|
+$967M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.59B |
| 2 |
GE Aerospace
GE
|
+$1.78B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 5 |
Philip Morris
PM
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.21% |
| 2 | Healthcare | 15.42% |
| 3 | Financials | 10.99% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Communication Services | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Levi Strauss
LEVI
$8.63B
| $350K | ﹤0.01% |
17,502
+4,202
| +32% | +$73K |
|
|
DM
2352
DELISTED
Desktop Metal, Inc.
DM
| $350K | ﹤0.01% |
39,728
+15,887
| +67% | +$102K |
|
2353
ChargePoint
CHPT
$160M
| $349K | ﹤0.01% |
9,172
+3,193
| +53% | +$125K |
|
2354
PAR Technology
PAR
$770M
| $348K | ﹤0.01% |
7,655
+954
| +14% | +$42.2K |
|
2355
Pure Cycle
PCYO
$273M
| $348K | ﹤0.01% |
36,590
+5,994
| +20% | +$59.3K |
|
2356
Reynolds Consumer Products
REYN
$5.55B
| $348K | ﹤0.01% |
12,168
+1,726
| +17% | +$48.6K |
|
|
EARN
2357
Ellington Residential Mortgage REIT
EARN
$167M
| $347K | ﹤0.01% |
50,200
| – | – |
|
2358
Stem
STEM
$55.9M
| $347K | ﹤0.01% |
7,905
+2,486
| +46% | +$138K |
|
2359
LSI Industries
LYTS
$912M
| $345K | ﹤0.01% |
22,770
+993
| +5% | +$14K |
|
2360
Tootsie Roll Industries
TR
$3.02B
| $345K | ﹤0.01% |
+11,407
| New | +$346K |
|
|
YMAB
2361
DELISTED
Y-mAbs Therapeutics
YMAB
| $345K | ﹤0.01% |
21,158
+1,657
| +8% | +$22.3K |
|
|
ACR
2362
ACRES Commercial Realty
ACR
$101M
| $343K | ﹤0.01% |
24,390
| – | – |
|
|
CIO
2363
DELISTED
City Office REIT
CIO
| $343K | ﹤0.01% |
65,764
+2,454
| +4% | +$12.4K |
|
|
ALEX
2364
DELISTED
Alexander & Baldwin
ALEX
| $342K | ﹤0.01% |
20,739
+2,613
| +14% | +$44.9K |
|
|
RVNC
2365
DELISTED
Revance Therapeutics, Inc.
RVNC
| $342K | ﹤0.01% |
69,361
+15,496
| +29% | +$91.7K |
|
2366
Commercial Vehicle Group
CVGI
$130M
| $340K | ﹤0.01% |
52,859
+1,238
| +2% | +$8K |
|
|
STEL
2367
DELISTED
Stellar Bancorp
STEL
| $340K | ﹤0.01% |
13,922
+1,750
| +14% | +$43.5K |
|
2368
Acacia Research
ACTG
$449M
| $338K | ﹤0.01% |
63,244
+3,018
| +5% | +$12.6K |
|
2369
World Acceptance Corp
WRLD
$875M
| $338K | ﹤0.01% |
2,329
+107
| +5% | +$14K |
|
2370
AvePoint
AVPT
$2.91B
| $337K | ﹤0.01% |
42,464
+5,316
| +14% | +$41.8K |
|
2371
Community Health Systems
CYH
$419M
| $337K | ﹤0.01% |
96,027
+6,852
| +8% | +$23.2K |
|
|
PLGO
2372
Pelagos Insurance Capital
PLGO
$1.95B
| $337K | ﹤0.01% |
+17,256
| New | +$254K |
|
|
VERV
2373
DELISTED
Verve Therapeutics
VERV
| $337K | ﹤0.01% |
25,366
+5,600
| +28% | +$74.3K |
|
|
TELL
2374
DELISTED
Tellurian Inc.
TELL
| $337K | ﹤0.01% |
508,768
+28,634
| +6% | +$19.4K |
|
2375
SI-BONE Inc
SIBN
$849M
| $336K | ﹤0.01% |
20,494
+1,372
| +7% | +$25.8K |
|
Similar funds
T. Rowe Price Associates's Q1 2024 Portfolio in Review
As of Q1 2024, T. Rowe Price Associates held 3,021 positions worth $816B, up 9.6% from $744B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2024 filing shows 108 new, 1,941 increased, 738 reduced and 64 closed positions. Its largest new stake was GE Vernova: 2,687,194 shares worth $367M. The largest sale was NVIDIA, an estimated $2.59B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2024 buy was GE Vernova: 2,687,194 shares worth $367M.
- T. Rowe Price Associates added most to Fortinet in Q1 2024, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $2.59B.
- T. Rowe Price Associates fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $621M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $816B portfolio in Q1 2024.
- T. Rowe Price Associates opened 108 new positions and closed 64 in Q1 2024.
- T. Rowe Price Associates's portfolio value rose 9.6% quarter-over-quarter to $816B.
Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.